David Roth
CIK: 0001599014
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syros Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 18, 2024SYRS
Syros Pharmaceuticals, Inc.
Sale(S)Direct12.1K shares at avg. $0.20$2K - Oct 31, 2024SYRS
Syros Pharmaceuticals, Inc.
Exercise(M)Direct18.9K shares- - Oct 31, 2024SYRS
Syros Pharmaceuticals, Inc.
Tax Payment(F)Direct6.8K shares at avg. $2.09$14K
1-3 of 3 transactions
David Roth files insider reports with the SEC as Chief Medical Officer of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 3 reported Form 4/5 transactions by David Roth since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 18, 2024.
About Roth David
Roth David (SEC CIK 0001599014) files insider reports with the SEC as Chief Medical Officer of Syros Pharmaceuticals, Inc. (SYRS).
Signal8 holds 2 ownership filings by Roth David, all Form 4s, filed between Nov 4, 2024 and Nov 20, 2024. Those filings report 3 transactions, from Oct 31, 2024 to Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Roth David's filings is in CAMBRIDGE, MA.
Recent filings by Roth David
Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)
- Simonian Nancy A, Director
- Stephens Kristin, Chief Development Officer
- Quirk Gerald E, Chief Legal & Compliance Offic
- Chee Conley, President & CEO
- Haas Jason, Chief Financial Officer
- AKKARAJU SRINIVAS, Director